US GAAP: Issues and solutions for pharmaceuticals and life sciences industry

  • Print-friendly version
11/20/2013 by Pharmaceuticals & life science
US GAAP: Issues and solutions for pharmaceuticals and life sciences industry

At a glance

This publication highlights factors the industry should consider and provides guidance on the most pertinent accounting solutions under US GAAP. The solutions presented are meant to provide a framework for determining the appropriate accounting answer for general solutions.

We hope you find this publication useful in addressing and understanding the accounting for certain transactions encountered in your business. Further, we hope that this publication will encourage consistent practices by companies in financial reporting under US GAAP. This consistency will be critical to the continued usefulness and transparency of medical technology companies' financial statements.

Further reading:

US GAAP: Issues and solutions for the medical technology industry - September 2013